BRIDGEWATER, N.J.--(BUSINESS WIRE)--Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on developing orphan treatments for rare pulmonary diseases, today announced that company management will participate at the 2015 UBS Global Healthcare conference taking place at the Sheraton New York Times Square Hotel from May 18 to May 20. Will Lewis, president and chief executive officer of Insmed, will participate in an analyst-led fireside chat on Monday, May 18 at 4:00 PM ET.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
